Taffic Tablets Hetero Treatment Hiv

Product Description TAFFIC, a once-a-day single pill, is a combination of three medicines - Bictegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg). The product is indicated for the treatment of human immunodeficiency virus type (HIV-1) infection in adults who have no antiretroviral treatment history or replacing the current antiretroviral regimen in those who have viral copies less than 50 per ml in the blood at least for three months with no prior treatment failure and resistance to any components. The 3-in-1 combination drug helps to prevent HIV from multiplying and works together to decrease the amount of HIV in the patient's blood to undetectable levels. This lowers the prospects of patients developing various HIV associated illnesses, thereby improving their quality of life. Studies suggest that the combination of Bictegravir, Emtricitabine, and Tenofovir Alafenamide has shown high antiviral efficacy and safety profile in HIV patients. TAFFIC is manufactured in Hetero's world-class manufacturing facility in Hyderabad, India, which is approved by international regulatory bodies.